Steep margins allow room for malpractice: Pharmaceuticals secretary

NEW DELHI: Steep margins on medicines are a concern as they can push a product or influence its selection, with government tightening its glare on errant healthcare players including companies and hospitals, pharmaceuticals secretary Manoj Joshi said. Joshi elaborated on the unethical practices in healthcare industry, just before govt announced capping of trade margins at 30% on all cancer drugs Thursday.

The Indian government is addressing concerns related to high trade margins on cancer medications. Pharmaceutical Secretary Manoj Joshi highlighted unethical practices occurring within the healthcare industry. He noted that hospitals often prefer expensive medicines that provide higher margins. Additionally, smaller manufacturers may engage in practices that create unethical relationships with doctors or retailers. Efforts are being made to improve the viability of government-run stores selling low-cost medicines.

Summarised by Agaah from Times of India. Agaah aggregates 36 sources and removes duplicate coverage — all news, one place.